|
Online edition of India's National Newspaper Saturday, April 28, 2001 |
|
Front Page |
National |
Southern States |
Other States |
State Elections |
International |
Opinion |
Business |
Sport |
Miscellaneous |
Features |
Classifieds |
Employment |
Index |
Home |
|
Business
| Previous
| Next
Gujarat Ambuja Cements net up 32 p.c.
Gujarat Ambuja Cements has posted a net profit of Rs. 65.69
crores for the third quarter ended March 31, 2001 against Rs
49.90 crores an increase of 32 per cent over the corresponding
period last year.
During the third quarter, it sold 15.42 lakh tonne of cement
against 14.98 lakh tonne in the same period last year. The
turnover during the period was Rs. 386.25 crores against Rs.
331.48 crores, an increase of 17 per cent.
The operating profit is up by 27 per cent at Rs. 132.02 crores
against Rs. 103.61 crores in the previous year. The net profit
has been arrived after charging an interest of Rs. 31.95 crores
against Rs. 22.81 crores in the same period last year. The
depreciation was Rs. 34.38 crores against Rs. 30.90 crores.
``The Company has commissioned its half million tonne cement
grinding unit at Bhatinda, Punjab,'' stated a press release
issued by Ambuja Cement. With the commissioning of this unit, the
company will be able to cater to South Punjab market. Work on its
two million tonne cement plant at Chandrapur, Maharashtra is
progressing fast and Company expects to complete the cement
project on schedule in December 2001.
Exide Industries
Exide Industries has announced a lower net profit of Rs. 41.50
crores for the year ended March 2001 against Rs. 48.89 crores in
the previous year. In spite of this, the company has announced a
dividend of 40 per cent, including an interim dividend of 25 per
cent made earlier.
Turnover for the year was marginally higher at Rs. 954 crores
against Rs. 939 crores. Net sales were at Rs. 770 crores against
Rs. 752 crores. The operating profit was Rs. 140.80 crores
against Rs. 146 crores.
The dividend has been declared keeping in mind the future
prospects and the company's healthy reserves position, according
to a company press release.
According to the chairman, Mr S. B. Ganguly, the results
reflected the company's concerns over the liberalised import
regime that has left an uneven playing field for the indigenous
battery industry. He hoped the government would take a positive
view on `anomalous' customs duty structure on raw materials and
finished products.
Glaxo
Glaxo India has reported a 27.87 per cent decline in net profit
at Rs. 10.17 crores for the first quarter ended March 31, 2001
against Rs. 14.10 crores in same period of previous fiscal.
Net sales have risen marginally to Rs. 194.36 crores from Rs.
183.24 crores. Other income accounted for Rs. 63.70 crores (Rs.
80 crores).
Interest charges have risen to Rs. 2.27 crores (Rs. 2.08 crores).
Depreciation claims Rs. 3.78 crores (Rs. 3.93 crores).
The profit before tax has grown by 12.3 per cent against net
sales growth of 6.1 per cent, after excluding profit on sale of
brands, income from investments/property rentals and expenses on
restructuring/integration pursuant to the proposed amalgamation
of Smithkline Beecham Pharmaceuticals India with the company.
Cipla
Cipla has announced a net profit of Rs. 178.42 crores for the
year ended March 2001 against Rs. 133.06 crores in the previous
year. Net sales were higher at Rs. 1,047.65 crores against Rs.
759.75 crores. Other income amounted to Rs. 39.60 crores (Rs.
35.74 crores). The company provided Rs. 91 lakhs (Rs. 1.14
crores) for interest, Rs. 15.50 crores (Rs. 13.34 crores) for
depreciation and Rs. 60.50 crores (Rs. 39.60 crores) for tax.
During the year, exports jumped by 84 per cent to Rs. 258 crores
(Rs. 140 crores).
For the fourth quarter ended March 2001, the company reported a
net profit of Rs. 34.36 crores (Rs. 29.08 crores) on a net sales
of Rs. 260.56 crores (Rs. 172.10 crores). Other income amounted
to Rs. 13.86 crores (Rs. 11.76 crores). The company provided Rs.
9 lakhs (Rs. 13 crores) for interest, Rs. 3.25 crores (Rs. 2.50
crores) for depreciation and Rs. 11 crores (Rs. 3.75 crores) for
tax.
Cadbury
Cadbury India has declared a net profit of Rs. 12.39 crores in
the first three months ended March 31, 2001 against Rs. 10.50
crores. Despite sluggish market conditions the company grew both
in domestic and exports market. Net sales were higher at
Rs.149.91 crores against Rs. 139.34 crores and the gross profit
before depreciation and taxation Rs. 26.47 crores against Rs.
21.18 crores.
Philips
Philips has posted a net loss of Rs. 6.36 crores for the first
quarter ended March 31, 2001, compared to a net loss of Rs. 11.86
crores in same period of previous year. Total income in Q1 was
Rs. 346.56 crores as against Rs. 326.58 crores in corresponding
period of last year.
According to the company the general slowdown in market
particularly in consumer durables and expendables will continue
to impact PIL's performance. The management saw 2001 as a year of
challenge, it said.
PIL has incurred an expenditure of Rs. 8.55 crores in Q1 on its
voluntary retirement scheme, the notice added.
Rolta India
Rolta India has reported a total income of Rs. 80.22 crores in
the quarter ended March 31, 2001 against Rs. 58.70 crores in the
corresponding period of the previous year, a growth of 36.7 per
cent. The cash profit was Rs. 38.15 crores reflecting an
operating margin of 47.6 per cent. The net profit after
depreciation has risen by 43.7 per cent to Rs. 30.70 crores from
Rs. 21.36 crores.
Aptech
Aptech has reported a net profit of Rs. 2.72 crores for the first
quarter ended December 31, 2001, an increase of 35.17 per cent
over the corresponding period in the previous year. Total global
revenues are higher by 21.40 per cent at Rs. 104.28 crores. Of
this income from Indian operations is Rs. 66.98 crores and other
income Rs. 2.73 crores.
Of the total operating income of Rs. 66.98 crores, the training
and education division accounted for Rs. 60.08 crores and the
software division Rs. 6.91 crores.
Send this article to Friends by E-Mail
|
|
Section : Business Previous : SEBI proposals send Sensex reeling Next : Cipla to supply anti-AIDS drugs to Nigerian Govt. | |
|
Front Page |
National |
Southern States |
Other States |
State Elections |
International |
Opinion |
Business |
Sport |
Miscellaneous |
Features |
Classifieds |
Employment |
Index |
Home | |
|
Copyrights © 2001 The Hindu Republication or redissemination of the contents of this screen are expressly prohibited without the written consent of The Hindu |
|